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Abstract
Isolated splenic metastasis from lung cancer is a very rare occurrence with only a few reports available. Here, we
report the case of a 82-year-old male who underwent a bilobectomy for a lung squamous cell carcinoma and 16
months later developed an isolated splenic metastasis. Additionally, previous reports are reviewed and discussed.
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Introduction
Isolated splenic metastasis from lung cancer is an
exceedingly rare event. Here, we present the case of an
82-year-old male with previously excised lung squamous
cell carcinoma who developed local recurrence and a
splenic metastasis. This is only the 17th known report of
isolated splenic metastasis, including English and non-
English literature.
Case Report
In April 2006, an 82-year-old former smoker male was
investigated due to persistent cough. A Computed
Tomographic (CT) scan of the chest showed a 2.2 × 1.5
cm nodule in the right mid-lung. Bronchoscopic biop-
sies revealed a moderately differentiated Squamous cell
carcinoma (Figure 1). Preoperative investigation showed
no mediastinal lymphadenopathy or distant metastatic
disease.
The patient underwent a right bilobectomy confirming
a moderately differentiated squamous cell carcinoma
with large polygonal cells, keratinization, intercellular
bridges and keratin pearls (pT2pN2). As margins were
scanty, adjuvant chemo-radiation was indicated (4 cycles
of Carboplatin and Paclitaxel and 50 Gy). Patient
remained asymptomatic and sixteen months after sur-
gery a CT scan revealed a 1 × 1 cm cystic lesion in the
spleen (Figure 2). Follow-up was lost and a new CT
scan was only performed one year later. This exam
revealed an interlobular thickening and an enlargement
of the splenic lesion now measuring 6.5 × 6.4 cm
(Figure 2). The patient was then referred to palliative
chemotherapy with Gemcitabine and received 4 cycles
(3 of them with reduced dose due to mielotoxicity). A
new CT scan showed stability of the pulmonary disease
but progress of the splenic lesion (7.8 × 7.8 cm - Figure
2). Splenectomy was then indicated. During preoperative
period the patient presented an acute bowel obstruction.
A CT scan of the abdomen and pelvis showed an abrupt
obstrutive point at the level of the left colon and the
patient underwent an urgent laparotomy. Surgical find-
ings consisted of the large splenic lesion without inva-
sion of adjacent structures and a left colon neoplasm.
Left colectomy with terminal Hartmann’s colostomy
and splenectomy were performed in January 2011.
Pathologic findings consisted of a splenic metastasis
with the red pulp being invaded by a moderately differ-
entiated squamous cell carcinoma with keratinization
and intercellular bridges (Figure 3 and 4). The lesion
measured 12 × 11 × 5 cm and was restricted to the
splenic capsule. The colonic lesion consisted of a mod-
erately differentiated Adenocarcinoma composed of
complex and irregular glands and tubules, with loss of
nuclear polarity and necrotic debris. It invaded the sub-
serosal and 3 out of 19 lymph nodes were compromised
(pT3pN1b) - Figure 5.
At the present time, twelve months after the proce-
dure, the patient remains well, with stable lung disease
and no other sites of disseminated metastasis from both
cancers.
* Correspondence: roncon86@hotmail.com
Sao Paulo’s Cancer Institute, Sao Paulo, Brazil
Dias et al. World Journal of Surgical Oncology 2012, 10:24
http://www.wjso.com/content/10/1/24 WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
© 2012 Dias et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Discussion
Splenic metastasis from solid organ cancers are rare. In
medical literature, there are less than 100 cases reported
[1]. Kinoshita et al reported splenic metastasis in 15 of 267
autopsies for lung cancer (5.6%), and in all these cases dis-
seminated abdominal disease was also present [2]. Isolated
splenic metastasis from lung cancer is extremely rare.
Until the present moment only 16 cases could be found in
the literature, including 3 non-English reports. Table 1
summarizes these reports. The present report was consid-
ered as an isolated metastasis. Unfortunately, the bilobect-
omy failed to achieve local control of the disease.
In the present case the pathologic confirmation of the
lesions was achieved through histologic analysis. As can
be observed in the supplemental figures, the colonic
tumor was truly an adenocarcinoma with no squamous
cell component, while the splenic lesion was unques-
tionably a squamous cell carcinoma. As so, further stu-
dies such as immunohistochemistry were precluded as
they could not provide additional information.
Splenic resistance for metastatic seeding is probably
due to its high density of immune-system cells and high
concentration of angiogenesis inhibition factor [3,4].
Considering lung cancer isolated splenic metastasis,
most patients remain asymptomatic and the diagnosis is
usually made during routine follow-up investigation.
However, abdominal pain, fever and splenic ruptures
may occur (Table 1).
The interval between the diagnosis of the primary tumor
and the splenic lesion varies widely (concomitantly or even
before the primary cancer is diagnosed, until up to 8 years
after the lung resection - Table 1). In most reports the pri-
mary tumor was located in the left lung, which is in agree-
ment with Kinoshita et al autopsies findings [2]. The
higher blood flow to the left lung as compared to the right
lung may be a reason for this occurrence.
Splenectomy is probably the best therapeutic option
for the isolated splenic metastasis and possibly the only
Figure 1 Endobronchial biopsy: Squamous cell carcinoma (*)
composed of sheets of large polygonal cells exhibiting
keratinization, intercellular bridges and keratin pearls (arrow).
HE, 200×.
Figure 2 CT scan of the splenic metastasis at postoperative
months 16, 28 and 30 (right to left).
Figure 3 Splenic metastasis from squamous cell carcinoma of
the esophagus. Splenic capsule (*), white pulp (**) and red pulp
(***) invaded by squamous cell carcinoma. HE, 100×.
Figure 4 Red pulp (*) invaded by the squamous cell carcinoma
(**). Tumor cells exhibit keratinization and intercellular bridges and
keratin pearls. HE, 200×.
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chance for cure. Long term survival can be obtained
with the procedure, as shown by Takada et al who had
an eight year disease free patient following the splenic
resection [5]. Before referring the patient for surgery, a
full body work-up, including PET-CT to exclude other
possible sites of disease, should be recommended.
Patients with complications related to the splenic lesion,
such as rupture or bleeding should also undergo sple-
nectomy, independently of other metastatic sites.
Cases with local recurrence and splenic metastasis,
such as the present report, should have their therapy
individualized. Splenectomy can be advised for those
patients with a controlled local recurrence associated
with a splenic lesion enlargement despite chemother-
apy or with a large enough lesion so a rupture risk
exists.
The coexistence of an obstructed left colonic Adeno-
carcinoma along the follow-up of this case is probably
a coincidence. Although, a genetic study could possibly
demonstrate pro-carcinogenic factors and mutations,
both tumors have different origins and risk factors.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and the accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Figure 5 Invasive adenocarcinoma of the sigmoid colon,
invading through the muscularis propria (*) into the
subserosal adipose tissue (**). HE, 100×.
Table 1 All currently reported cases of isolated splenic metastasis.
First author and
Reference
Primary lung lesion Lung lesion
side
Time to splenic
metastasis
Metastasis
symptoms
Follow-up at time
of report
Klein[6] Bronchioalveolar carcinoma Left 20 months Abdominal pain Died 49 months after
splenectomy
Edelman[7] Poorly differentiated
Adenocarcinoma
Left 0 Asymptomatic -
Macheers[8] Large cell undifferentiated Carcinoma Left 0 Asymptomatic Died 1 month after
splenectomy
Gupta[9] Keratinous moderately differentiated
Squamous cell Carcinoma
Right 0 Splenic rupture Died 8 weeks after
splenectomy
Kinoshita[2] Lung squamous cell Left 14 months Asymptomatic Died 27 months after
splenectomy
Takada[5] Bronchopulmonary carcinoid Left 8 years Abdominal pain Disease free after 8
years
Tomaszewski[10] Lung cancer Left 0 Asymptomatic -
Massarweh[3] Poorly differentiated Adenocarcinoma Left 0 Splenic rupture -
Schmidt[11] Moderately differentiated
Adenocarcinoma
Left 4 years Asymptomatic Disease free after 2
years
Pramesh[12] Squamous cell Carcinoma Left 2 months Asymptomatic -
Lachachi[13] Poorly differentiated Carcinoma Right 0 Splenic rupture -
Sanchez-Romero[4] Adenocarcinoma Left 0 Abdominal pain -
Van Hul[14] Adenocarcinoma Left 2 years Asymptomatic -
Ando[15] Squamous cell carcinoma Right 13 months Asymptomatic -
Chloros[16] Moderate-to-low differentiated squamous cell
Carcinoma
Right 0 Asymptomatic -
Tang[17] Undifferentiated large cell Carcinoma Right 3 months Fever -
Present report Moderately differentiated Squamous cell
Carcinoma
Right 16 months Asymptomatic Alive after 12 months
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